Molecular apocrine differentiation is a common feature of breast cancer in patients with germline PTEN mutations
Authors:
- Guillaume BanneauGBGuillaume Banneau
- Mickaël GuedjMGMickaël Guedj
- Gaëtan MacGroganGMGaëtan MacGrogan
- Isabelle de MascarelIMIsabelle de Mascarel
- Valerie VelascoVVValerie Velasco
- Renaud SchiappaRSRenaud Schiappa
- Valerie BonadonaVBValerie Bonadona
- Albert DavidADAlbert David
- Catherine DugastCDCatherine Dugast
- Brigitte Gilbert-DussardierBGBrigitte Gilbert-Dussardier
- Olivier IngsterOIOlivier Ingster
- Pierre VabresPVPierre Vabres
Open Access
- 16 August 2010
- journal article
- research article
- Published by Springer Nature in Breast Cancer Research
- Vol. 12 (4) , R63
Abstract
Introduction: Breast carcinoma is the main malignant tumor occurring in patients with Cowden disease, a cancer-prone syndrome caused by germline mutation of the tumor suppressor gene PTEN characterized by the occurrence throughout life of hyperplastic, hamartomatous and malignant growths affecting various organs. The absence of known histological features for breast cancer arising in a PTEN-mutant background prompted us to explore them for potential new markers. Methods: We first performed a microarray study of three tumors from patients with Cowden disease in the context of a transcriptomic study of 74 familial breast cancers. A subsequent histological and immunohistochemical study including 12 additional cases of Cowden disease breast carcinomas was performed to confirm the microarray data. Results: Unsupervised clustering of the 74 familial tumors followed the intrinsic gene classification of breast cancer except for a group of five tumors that included the three Cowden tumors. The gene expression profile of the Cowden tumors shows considerable overlap with that of a breast cancer subgroup known as molecular apocrine breast carcinoma, which is suspected to have increased androgenic signaling and shows frequent ERBB2 amplification in sporadic tumors. The histological and immunohistochemical study showed that several cases had apocrine histological features and expressed GGT1, which is a potential new marker for apocrine breast carcinoma. Conclusions: These data suggest that activation of the ERBB2-PI3K-AKT pathway by loss of PTEN at early stages of tumorigenesis promotes the formation of breast tumors with apocrine features.Keywords
This publication has 44 references indexed in Scilit:
- Kerfdr: a semi-parametric kernel-based approach to local false discovery rate estimationBMC Bioinformatics, 2009
- Phosphatase and Tensin Homologue Deleted on Chromosome 10 Deficiency Accelerates Tumor Induction in a Mouse Model of ErbB-2 Mammary TumorigenesisCancer Research, 2008
- Recurrent gross mutations of the PTEN tumor suppressor gene in breast cancers with deficient DSB repairNature Genetics, 2007
- Concordance among Gene-Expression–Based Predictors for Breast CancerNew England Journal of Medicine, 2006
- Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profilesProceedings of the National Academy of Sciences, 2005
- A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast CancerNew England Journal of Medicine, 2004
- The COSMIC (Catalogue of Somatic Mutations in Cancer) database and websiteBritish Journal of Cancer, 2004
- Repeated observation of breast tumor subtypes in independent gene expression data setsProceedings of the National Academy of Sciences, 2003
- Gene expression profiling predicts clinical outcome of breast cancerNature, 2002
- Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implicationsProceedings of the National Academy of Sciences, 2001